Team Trobalt Update — April 9, 2015

Discussion in 'Awareness & Fundraising' started by Tinnitus Talk, Apr 9, 2015.

Thread Status:
Not open for further replies.
    1. Message From Team Trobalt

      As members of this forum may be aware we, Team Trobalt, have been in contact with a number of researchers in relation to the petition to the ATA (there is a thread by the same name, see: Besides TRI, Team Trobalt continues to remain in contact with a group of researchers in the United States who are conducting research into pharmacological approaches for the treatment of tinnitus. The expert within the team of researchers is Prof. Ernest J. Moore:

      The team of researchers has been kind to share a few insights of their focus areas with us. Since tinnitus research often receives little "publicity", we would like to take the opportunity to share a couple of those details with the tinnitus community in a message of awareness. Below, a few facts therefore from Prof. Moore (and colleagues) on their current research initiatives:
      Team Trobalt finds the work of this team of professors particularly interesting as their research involves looking for possible pharmacological treatments using existing drugs on the market. The implication of this approach is that a treatment can potentially be made available much sooner (as compared with a new drug candidate). This would include - as an example - a clinical test of Trobalt (Retigabine).

      The in vitro efficacy of Trobalt (and three other drugs) has already been evaluated by the team of researchers in a recently released paper. The paper is now available for free and in its entirety at:

      Prof. Moore has previously given interviews, and although some of them are from a few years ago, the content is still very much relevant:

      Prof. Moore's research on zebrafish - as mentioned in the article - is likewise available online:

      In our experience, two observations seem to describe tinnitus research accurately:
      1. The research often receives little attention from the public.
      2. The research is often underfunded.
      For the above two reasons, Team Trobalt will therefore continue to liaise with various scientists conducting pharmacological research of tinnitus in order to promote awareness and share interesting developments. We also aim to investigate funding initiatives at some point (more on this later on).

      Team Trobalt
      • Like x 50
      • Informative x 4
      • Agree x 1
      • Helpful x 1
      • Genius x 1
      • Useful x 1

Share This Page

Thread Status:
Not open for further replies.